Stuart Raetzman

CEO, Galderma

Stuart Raetzman is a life science industry executive with demonstrated success across multiple healthcare businesses including pharmaceuticals, biologics, disposable medical devices, implantable medical devices, capital equipment and over-the-counter products. He understands the global marketplace, having lived in Europe while leading a global enterprise. Over his career, Raetzman has built sustainable organizations by identifying and developing talent, committing to high standards of ethical behavior, and creating cultures built on trust.

As the Chief Executive Officer of Galderma, Stuart led a dramatic turnaround of the Nestle-owned stand-alone business and positioned the company for new ownership. He led the sale process as Nestle divested the business to the private equity firm EQT Partners. Based in Lausanne, Switzerland, Galderma is a global leader in dermatologic pharmaceutical, injectable and over the counter products with over 5,000 employees working across 35 affiliates. Annual sales are $3.0 billion.

Stuart helped Nestle Skin Health identify new indications and product segments to enter. Under his leadership, Galderma secured a licensing agreement with Chugai, which allowed Galderma to develop the monoclonal antibody nemolizumab for multiple indications. He broadened the relationship with Ipsen by expanding geographic rights, development, and commercialization of Azzalure.

Operationally, Stuart completely re-structured the business to lower costs in manufacturing, R&D, the home office, and in the affiliates. Savings funded projects in a re-invigorated pipeline and significantly increased profitability. He restructured Western Europe and Latin America to allow for investment in China, Southeast Asia and the Middle East. Sales growth accelerated during the re-structuring program.

Prior to his time at Galderma, Stuart spent his career in the ophthalmic business with Allergan, Chiron Vision, and he spent over 20 years with Alcon Laboratories. He displayed operational and strategic leadership as he led large teams in the U.S. and on international assignment in Europe. He led the Alcon U.S. organization with 2,500 associates and in his last role, he lived in Switzerland and led a team of more than 4,000 associates across Europe, the Middle East and Africa (EURMEA). He also spent time as the Head of Global Strategy for Alcon.

In 2004, Stuart completed the Advanced Management Program at the Harvard Business School. He holds a Bachelor’s degree in marketing from the University of Texas.